Arnoldo Piccardo

Dr. Arnoldo Piccardo

Nuclear Medicine Unit, E.O. Ospedali Gallieradisabled, Genoa, Italy
orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2018 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
Arnoldo PiccardoArnoldo Piccardo
Arnoldo Piccardo
AIAlessio Imperiale
Alessio Imperiale
KSKlaus Strobel
Klaus Strobel
PKPhilipp A. Kaufmann
Philipp A. Kaufmann
LGLuca Giovanella
Luca Giovanella

7 August 2019 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
LGLuca Giovanella
Luca Giovanella
AAAnca M. Avram
Anca M. Avram
Ioannis IakovouIoannis Iakovou
Ioannis Iakovou
JKJennifer Kwak
Jennifer Kwak
SLSusan A. Lawson
Susan A. Lawson
EWEly Wolin
Ely Wolin

1 November 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
FBFrancesco Bertagna
Francesco Bertagna
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
Arnoldo PiccardoArnoldo Piccardo
Arnoldo Piccardo
RGRaffaele Giubbini
Raffaele Giubbini
Context: Thyroid incidentaloma diagnosed by 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (F-18-FDG-PET/CT) is defined as a thyroid uptake incidentally and newly detected in a patient studied for nonthyroid purpose. In this review, we have comprehensively analyzed the diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas revealed during studies performed for an unrelated and nonthyroid purpose. Evidence Acquisition: A comprehensive literature research of the PubMed/MEDLINE databases was conducted to find relevant published articles about the F-18-FDG-PET or F-18-FDG-PET/CT thyroid incidentalomas. Evidence Synthesis: All studies considered in this review have investigated a very large number of patients, achieving overall about 147,505 units. The pooled incidence of thyroid incidentalomas detected by F-18-FDG-PET or PET/CT was 2.46% (95% confidence interval, 1.68–3.39%). The malignancy ratio was 34.6% (95% confidence interval, 29.3–40.2%). Conclusion: F-18-FDG-PET/CT thyroid incidentaloma is a relevant clinical finding; diffuse uptakes and most focal uptakes are commonly caused by benign diseases, whereas about one third of focal uptakes are malignant; the most frequent malignant histological type responsible for F-18-FDG-PET/CT thyroid incidentaloma is papillary thyroid carcinoma.

20 September 2011 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
Arnoldo PiccardoArnoldo Piccardo
Arnoldo Piccardo
Egesta LopciEgesta Lopci
Egesta Lopci
MCMassimo Conte
Massimo Conte
AGAlberto Garaventa
Alberto Garaventa
LFLuca Foppiani
Luca Foppiani
SFStefano Fanti
Stefano Fanti

6 March 2013 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
LGLuca Giovanella
Luca Giovanella
PTPierpaolo Trimboli
Pierpaolo Trimboli
FVFrederik A. Verburg
Frederik A. Verburg
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
Arnoldo PiccardoArnoldo Piccardo
Arnoldo Piccardo
LCLuca Ceriani
Luca Ceriani

15 September 2018 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
Arnoldo PiccardoArnoldo Piccardo
Arnoldo Piccardo
PTP. Trimboli
P. Trimboli
MRM. Rutigliani
M. Rutigliani
MPM. Puntoni
M. Puntoni
LFL. Foppiani
L. Foppiani
LGL. Giovanella
L. Giovanella